Yuichiro Kondo

Title: The novel oral calcimimetic, evocalcet


Mr Yuichiro Kondo is a Project Leader at Nephrology R&D Management Office, Nephrology Unit, R&D Division Kyowa Kirin Co., Ltd. Japan. He is Responsible for the management of the R&D project of evocalcet and in charge of many CKD-MBD projects.

More about Yuichiro Kondo

April 2013-March 2018

Pharmacological Researcher of CKD-MBD, renal anemia and CKD,

Nephrology research laboratory in Kyowa Kirin Co., Ltd.

Experience engaged in preclinical pharmacological research on many clinical trial candidates, marketing products and introduced products in CKD-MBD, renal anemia and CKD such as cinacalcet, evocalcet, VDRA, phosphate binder, anti-FGF23 antibody and ESA.

April 2009-March 2013

Pharmacological Researcher of bone diseases,

Pharmacological Research laboratory in Kyowa Kirin Co., Ltd.

Preclinical research on bone diseases.



2007 Bachelor of Engineering, Department of Applied Chemistry, Keio University

2009 Master of Engineering, Department of Chemical Biology, Keio University


Publications and Presentations

Kondo Y, et al. The effects of cinacalcet on vagus nerve in miniature pigs. Kidney and Dialysis (in Japanese). 2017; 82: 455-460

Kengo Yamawaki, Yuichiro Kondo, et al. The soluble form of BMPRIB is a novel therapeutic candidate for treating bone related disorders. Scientific Reports. 2016; 6:18849


The effects of cinacalcet on vagus nerve in miniature pigs. Oral presentation in topic session, JAPAN CKD-MBD FORUM,?and oral presentation in oral session, JSDT in 2017

The novel oral calcimimetic, evocalcet. Invited speaker KSN 2019 in Korea


Professional Affiliations

Japanese Society of Dialysis and Transplantation JSDT

Research Interest

No Content found...